Acer Therapeutics Stock Price, News & Analysis

ACER NASDAQ

Company Description

Acer Therapeutics (NASDAQ: ACER) is a publicly traded pharmaceutical preparation manufacturing company in the Manufacturing sector.

ACER stock has declined 100.0% over the past year.

This page provides a comprehensive overview of ACER stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

-100%

Performance 1 year

$0.0

Market Cap

24.5M

Shares outstanding

Acer Therapeutics (ACER) stock. Over the past 12 months, the stock has lost 100.0%.

Latest News

View All

August 30, 2023

+109.84%

Acer Therapeutics Reacquires Worldwide Development, Commercialization and Economic Rights to OLPRUVA™ from Relief Therapeutics, Excluding the Geographical Europe

August 14, 2023

-18.92%

Acer Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update

earnings

June 26, 2023

-1.13%

Acer Therapeutics Receives $1 Million Capital Infusion from Chief Executive Officer and Founder

May 15, 2023

+2.55%

Acer Therapeutics Reports Q1 2023 Financial Results and Provides Corporate Update

earnings

May 1, 2023

-3.12%

Acer Therapeutics Announces OLPRUVA™ Commercial Launch Progressing Ahead of Schedule

March 27, 2023

-1.06%

Acer Therapeutics Reports Q4 and Full Year 2022 Financial Results and Provides Corporate Update

earnings

Acer Therapeutics has 10 recent news articles. Of the recent coverage, 2 articles coincided with positive price movement and 8 with negative movement. Key topics include earnings, offering, clinical trial. View all ACER news →

SEC Filings

View All

No SEC filings available for ACER.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

ACER Company Profile & Sector Positioning

Acer Therapeutics (ACER) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.